Dr. Avenard is CEO at GABC, a Strategic Advisory Firm for Biotech and Pharma Industry. Dr. Avenard is Board member or adviser for several companies and Chief Executive Officer of G1J-IDF, a seed venture fund in Life Sciences. From 1997 to 2010, he served as Chief Operating Officer of BioAlliance Pharma SA (BIO – NYSE-EURONEXT) since he co-founded the company. From 1990 to 1997, Dr. Avenard served as Medical Director of Development in the Cassenne Laboratories division of Hoechst Marion Roussel (Sanofi-Aventis Pharma). From 1976 to 1990, Dr. Avenard held various positions with the National Blood Transfusion Center in Paris, including Medical Director of Bio-Transfusion (LFB), providing human plasma products. He has also served as a physician in hemobiology and blood transfusion at the Blood Center of Pitié-Salpétrière Hospital in Paris. Dr. Avenard received his MD as well as degrees in hematology and hemobiology & blood transfusion from the School of Medicine at the University of Paris V. He is currently a member of the Biotech Working Group at LEEM and Expert at the Ministry of Research for Research Tax Credit.